Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iteos Therapeutics Inc
(NQ:
ITOS
)
16.85
-0.01 (-0.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
410,491
Open
16.99
Bid (Size)
6.750 (2)
Ask (Size)
18.50 (7)
Prev. Close
16.86
Today's Range
16.65 - 17.36
52wk Range
8.200 - 18.75
Shares Outstanding
35,763,742
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
iTeos to Participate in Upcoming Investor Conferences
August 28, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
August 20, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
+45.38%
+45.38%
1 Month
-4.21%
-4.21%
3 Month
+0.66%
+0.66%
6 Month
+49.51%
+49.51%
1 Year
+39.66%
+39.66%
More News
Read More
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024
August 08, 2024
Via
InvestorPlace
iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
Recap: ITeos Therapeutics Q4 Earnings
March 06, 2024
Via
Benzinga
iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
August 05, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK
July 08, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer
June 17, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
May 28, 2024
Via
Benzinga
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q1 2024
May 10, 2024
Via
InvestorPlace
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
May 10, 2024
Via
Benzinga
Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings
May 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Therapeutics Announces $120 Million Registered Direct Offering
May 10, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
April 07, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q4 2023
March 06, 2024
Via
InvestorPlace
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
March 06, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
March 06, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
March 05, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos to Participate in Upcoming Investor Conferences
March 01, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos Announces 2024 Strategic Priorities and Anticipated Milestones
January 08, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
iTeos Therapeutics Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.